WHO ICTRP trial
The risk factors associated with early mortality in patients with newly…
ChiCTR2100050231 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100050231 |
|---|---|
| Public title | The risk factors associated with early mortality in patients with newly diagnosed multiple myeloma: a prospective, multicenter, open-label and observational study |
| Scientific title | The risk factors associated with early mortality in patients with newly diagnosed multiple myeloma: a prospective, multicenter, open-label and observational study |
| Primary sponsor | The First Hospital of Jilin University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Countries | China |
| Conditions | multiple myeloma |
| Interventions | Gold Standard:Clinical outcome;Index test:prediction model |
| Registration date | Aug 23, 2021 |
| Target size | Target condition:200;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: